Working to Eradicate Gynecologic Cancers

277 - Poster Session A
Simvastatin, an HMG-CoA reductase inhibitor, exhibits antimetastatic and antitumorigenic effects in endometrial cancer

Saturday, March 22, 2014: 7:45 AM
West Exhibit Hall (Tampa Convention Center)
J. E. Stine, M. Schointuch, C. Zhou, T. Gilliam, X. Han, P. A. Gehrig and V. L. Bae-Jump
University of North Carolina at Chapel Hill, Chapel Hill, NC
 
See more of: Poster Session A
See more of: Poster Session
<< Previous Presentation | Next Presentation >>